Physician profile
Roman Y Royzman
NPI 1053322198
$2,237.97
in general payments reported to CMS, 2019-2025
13 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $111 · 2021: $286 · 2022: $125 · 2023: $410 · 2024: $892 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,716.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $565.60 | 2024-2025 | Synergy |
| Medtronic, INC. | $512.07 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Bardy Diagnostics, INC. | $241.17 | 2021 | |
| Biotronik INC. | $196.06 | 2024 | Pamira |
| Edwards Lifesciences Corporation | $153.97 | 2023 | Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $151.54 | 2023 | Mitraclip |
| Philips North America LLC | $124.86 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $110.69 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.99 | 2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.85 | 2024 | Lifevest |
| Siemens Medical Solutions USA, INC. | $17.97 | 2023 | Artis Icono Floor |
| Heartflow, INC. | $17.60 | 2025 | |
| Pfizer INC. | $15.60 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Royzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.